Becton Dickinson - 40 Year Stock Price History | BDX

Historical daily share price chart and data for Becton Dickinson since 1983 adjusted for splits and dividends. The latest closing stock price for Becton Dickinson as of September 29, 2023 is 258.53.
  • The all-time high Becton Dickinson stock closing price was 282.63 on July 27, 2023.
  • The Becton Dickinson 52-week high stock price is 287.32, which is 11.1% above the current share price.
  • The Becton Dickinson 52-week low stock price is 215.90, which is 16.5% below the current share price.
  • The average Becton Dickinson stock price for the last 52 weeks is 251.30.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 254.7891 253.3893 282.6270 228.0980 258.5300 2.78%
2022 244.3598 240.9348 269.5998 215.1226 251.5298 5.12%
2021 234.4553 235.3311 249.2513 223.6037 239.2886 1.88%
2020 230.7683 252.4194 264.8764 186.4078 234.8805 -6.75%
2019 227.5653 201.3298 253.2992 193.2064 251.8915 22.20%
2018 214.2259 196.7426 241.0638 190.8422 206.1234 6.62%
2017 174.6567 146.9598 205.4010 146.6484 193.3287 31.23%
2016 144.5436 129.4962 160.8375 116.3059 147.3158 9.23%
2015 124.8094 120.3370 137.0060 113.6503 134.8704 12.64%
2014 101.6765 92.2059 121.0221 89.0462 119.7347 28.27%
2013 81.9356 65.7468 93.4394 65.7468 93.3465 44.27%
2012 62.3409 60.1253 65.4820 58.6397 64.7041 7.23%
2011 63.9809 66.9904 71.6594 56.8009 60.3433 -9.70%
2010 58.7525 60.8894 67.4568 52.3419 66.8243 9.39%
2009 53.0422 53.0759 61.7570 46.1859 61.0908 17.57%
2008 61.1206 64.9366 69.0971 45.5449 51.9591 -16.92%
2007 58.0090 52.0137 63.6141 51.5854 62.5421 20.72%
2006 48.0853 44.0460 54.3126 42.7845 51.8069 18.34%
2005 40.4979 40.2732 44.2427 36.3483 43.7764 7.19%
2004 35.6741 29.1487 41.5819 29.1487 40.8413 39.74%
2003 25.6306 22.1405 29.4471 20.6734 29.2268 35.66%
2002 22.9796 23.0952 26.7594 17.4427 21.5438 -6.32%
2001 23.8881 23.4587 26.7590 20.7360 22.9980 -3.21%
2000 19.4402 17.7478 24.1037 15.3120 23.7606 30.15%
1999 21.5789 28.8230 28.8230 16.4331 18.2560 -36.20%
1998 25.0666 16.6195 31.3588 16.4533 28.6152 72.18%
1997 16.2001 14.2669 18.2666 14.2669 16.6195 16.49%
1996 13.4964 12.3170 14.6317 11.6893 14.2669 16.99%
1995 9.5335 7.7364 12.2793 7.7364 12.1951 58.45%
1994 6.6113 5.6484 7.9577 5.3918 7.6963 36.75%
1993 5.7295 6.0062 6.2186 5.0835 5.6279 -7.34%
1992 5.6411 5.0440 6.4542 4.9961 6.0734 16.68%
1991 5.3191 5.5844 6.0468 4.4140 5.2051 -6.48%
1990 4.8765 4.6020 5.6778 4.1243 5.5657 22.39%
1989 4.0326 3.6993 4.5476 3.5355 4.5476 21.16%
1988 3.8735 3.6575 4.3916 3.3497 3.7535 3.63%
1987 4.1149 3.5776 4.8413 3.1274 3.6220 2.50%
1986 3.3662 2.2044 4.3027 2.2044 3.5338 61.29%
1985 1.8564 1.4047 2.3012 1.4047 2.1909 56.48%
1984 1.2744 1.3340 1.4400 1.0912 1.4001 7.81%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $75.002B $18.870B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $58.662B 15.86
West Pharmaceutical Services (WST) United States $27.713B 47.56
Align Technology (ALGN) United States $23.367B 57.39
Cardinal Health (CAH) United States $21.388B 14.94
Labcorp (LH) United States $17.813B 12.52
Cooper (COO) United States $15.749B 26.33
Henry Schein (HSIC) United States $9.696B 15.22
DENTSPLY SIRONA (XRAY) United States $7.232B 19.30
Merit Medical Systems (MMSI) United States $3.976B 23.97
CONMED (CNMD) United States $3.100B 37.63
Patterson (PDCO) United States $2.841B 11.90
STAAR Surgical (STAA) United States $1.949B 70.49
Atrion (ATRI) United States $0.727B 26.92
SmileDirectClub (SDC) United States $0.167B 0.00
Lifevantage (LFVN) United States $0.082B 26.88
Pro-Dex (PDEX) United States $0.056B 12.36
Biolase (BIOL) United States $0.002B 0.00